使用PET/MRI在人体内进行三维心肌膜电位成像
研究在3名健康受试者中采用[18F]-FTPP+ PET/MR成像,结合动力学模型与细胞外容积分数测量,成功估算全心脏三维膜电位,各受试者全心肌膜电位分别为-144.7±3.5 mV、-160.7±5.3 mV和-165.8±3.1 mV。
要点
- 在3名健康受试者中成功实现人体在体三维心肌膜电位成像。
- 各受试者全心肌膜电位分别为-144.7±3.5 mV、-160.7±5.3 mV和-165.8±3.1 mV。
- 方法基于[18F]-FTPP+ PET/MR动态成像与Nernst方程动力学模型。
核心结论
- 所提出的方法可在人体在体条件下实现三维心肌膜电位成像。
研究设计与样本
- 在体PET/MR成像研究,纳入3名健康受试者(1名男性、2名女性;48±29岁),经当地机构审查委员会(IRB)批准的研究方案下进行。
主要发现
- [18F]-FTPP+采用弹丸加输注方案给药(弹丸活度301.2±7.6 MBq,输注活度90.0±4.9 MBq),弹丸注射后不久开始120分钟输注(输注时间,TOI)。
- 动态心脏PET/MR成像在TOI后约20分钟开始并持续100分钟。
- 细胞外容积分数成像通过心脏MR自由呼吸三维T1 mapping序列在对比剂(钆特酸葡胺,0.1 mmol/kg)注射前后完成。
- 采用基于线性切空间对齐(LTSA)模型的方法从稀疏采样(k,t)空间数据重建T1的高帧率动态图像,PET运动校正采用多分辨率两步刚性图像配准后接B样条变换的非刚性配准。
- 基于Nernst方程的动力学模型结合心肌示踪剂浓度、示踪剂分布容积和细胞外容积分数测量计算组织膜电位,3名受试者全心肌膜电位分别为-144.7±3.5 mV、-160.7±5.3 mV和-165.8±3.1 mV。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mitochondrial membrane potential is a key biophysical parameter of mitochondrial function, which can be useful for the diagnosis and treatment monitoring of various cardiac diseases. We present a non-invasive PET/MR imaging method for 3D myocardial membrane potential mapping in humans. RESULTS: An in vivo PET/MR imaging study was performed in three healthy subjects (1 male and 2 females; 48 ± 29 years old) under a study protocol approved by the local Institutional Review Board (IRB). Written informed consent was obtained from all subjects before participation in the study. The [18F](4-Fluorophenyl)triphenylphosphonium ([18F]-FTPP+) PET tracer was administered using a bolus-plus-infusion protocol (bolus activity of 301.2 ± 7.6 MBq, infusion activity of 90.0 ± 4.9 MBq), where an infusion of 120 min was started shortly after the bolus injection (time of infusion, TOI). Dynamic cardiac PET/MR imaging was performed approximately 20 min after the TOI and continued for 100 min. The extracellular volume fraction mapping was performed via cardiac MR with a free-breathing, 3D cardiac T1 mapping sequence before and after the contrast agent injection (gadoterate meglumine, 0.1 mmol/kg). A linear tangent space alignment (LTSA) model-based method was used to reconstruct high-frame-rate dynamic images from sparsely sampled (k,t)-space data for T1. PET motion correction was performed using two steps of rigid image registration in a multi-resolution fashion, followed by a non-rigid image registration with B-spline transform. The tissue membrane potential was calculated using a kinetic model based on the Nernst equation with myocardial tracer concentration, tracer volume of distribution, and extracellular volume fraction measurements. Fully 3D membrane potential maps were successfully estimated from all three subjects. The estimated whole-heart membrane potentials were - 144.7 ± 3.5 mV, - 160.7 ± 5.3 mV, and - 165.8 ± 3.1 mV for each subject. CONCLUSION: The proposed method allows 3D myocardial membrane potential mapping in humans in vivo.
引用
- Bijari FJ, Han PK, Marin T, et al. In vivo 3D myocardial membrane potential mapping in humans using PET/MRI. EJNMMI Res. 2025. PMID: 40715686. doi:10.1186/s13550-025-01287-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。